Rybodyn

San Diego, United States

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

$10.0M raised

Mar 2026

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Rybodyn raised?

Rybodyn has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in March 2026.

Who are Rybodyn's investors?

Rybodyn's investors include SeaX Ventures, SOSV, SOSV SF & NY (Fka IndieBio), Massive Tech Ventures, Swell Partners.

Where is Rybodyn headquartered?

Rybodyn is headquartered in San Diego, United States.

What does Rybodyn do?

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

What stage is Rybodyn at?

Rybodyn is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 24, 2026.

MLA

"Rybodyn — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/rybodyn. Accessed July 3, 2026.

APA

VCBacked. (2026). Rybodyn — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/rybodyn

Wikipedia (cite web)

{{cite web |title=Rybodyn — Funding & Investors |url=https://www.vcbacked.co/company/rybodyn |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 24, 2026.